Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-08-24

Clinical Trial Update: Role of Folinic Acid in Improving the Adaptive Skills and Language Impairment in Children With Autism Spectrum Disorder [Phase 2]

View source ↗

Summary

Phase 2 trial assessing folinic acid for improving adaptive skills and language impairment in children with autism spectrum disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Folinic acid (folinic acid)

Snippet

Sponsor: Nishtar Medical University | Conditions: Autism Spectrum Disorder | Phase 2 | Status: COMPLETED